# Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya

> **NCT06582966** · PHASE4 · COMPLETED · sponsor: **University of Washington** · enrollment: 60 (actual)

## Conditions studied

- STI

## Interventions

- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT06582966
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-13
- **Primary completion:** 2025-05-27
- **Final completion:** 2025-05-27
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06582966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06582966, "Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06582966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*